Liyam Laraba et al. reported that genetic ablation of the Hippo effectors YAP and TAZ and application of TEAD palmitoylation inhibitors suppressed the Hippo signaling pathway and regressed schwannoma and meningioma tumor growth both in-vivo and in-vitro [30]. Here, YAP1 is linked to neoplasm.